Endo Wields The Axe Again As It Eyes $95m Annual Savings
Two US Manufacturing Sites To Close; Other Measures Taken
Hundreds more jobs are to go at Endo under further cost-cutting measures, including the closure of multiple sites serving the US-based player’s Generics business. Management discussed the issue on Endo’s third-quarter earnings call.
